Stephens Investment Management Group LLC Pacira Bio Sciences, Inc. Transaction History

Stephens Investment Management Group LLC

$7.08 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$25.5 - $31.51 $1.41 Million - $1.74 Million	-55,184 Reduced 3.87%	1,371,561 $39.2 Million
Q1 2024 May 14, 2024	BUY	$27.7 - $35.48 $3.01 Million - $3.86 Million	108,740 Added 8.25%	1,426,745 $41.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $675,344 - $880,360	-25,659 Reduced 1.91%	1,318,005 $44.5 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $203,469 - $265,876	6,632 Added 0.5%	1,343,664 $41.2 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $5.96 Million - $7.84 Million	164,974 Added 14.08%	1,337,032 $53.6 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $127,517 - $155,690	3,589 Added 0.31%	1,172,058 $47.8 Million
Q4 2022 Jan 26, 2023	SELL	$38.19 - $57.45 $40,443 - $60,839	-1,059 Reduced 0.09%	1,168,469 $45.5 Million
Q3 2022 Nov 07, 2022	BUY	$51.24 - $58.89 $74,246 - $85,331	1,449 Added 0.12%	1,169,528 $62.2 Million
Q2 2022 Aug 03, 2022	BUY	$51.49 - $81.64 $404,917 - $642,016	7,864 Added 0.68%	1,168,079 $68.1 Million
Q1 2022 May 04, 2022	BUY	$60.03 - $76.49 $1.28 Million - $1.64 Million	21,405 Added 1.88%	1,160,215 $88.5 Million
Q4 2021 Feb 15, 2022	BUY	$47.97 - $62.21 $7.86 Million - $10.2 Million	163,928 Added 16.82%	1,138,810 $68.5 Million
Q3 2021 Oct 27, 2021	BUY	$54.64 - $61.3 $958,768 - $1.08 Million	17,547 Added 1.83%	974,882 $54.6 Million
Q2 2021 Aug 09, 2021	SELL	$59.18 - $69.99 $871,425 - $1.03 Million	-14,725 Reduced 1.51%	957,335 $58.1 Million
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $207,051 - $275,160	3,491 Added 0.36%	972,060 $68.1 Million
Q4 2020 Feb 10, 2021	SELL	$50.47 - $66.26 $1.5 Million - $1.97 Million	-29,769 Reduced 2.98%	968,569 $58 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $1.5 Million - $1.81 Million	-28,774 Reduced 2.8%	998,338 $60 Million
Q2 2020 Aug 24, 2020	SELL	$30.8 - $52.47 $6.59 Million - $11.2 Million	-214,077 Reduced 17.25%	1,027,112 $53.9 Million
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $524,548 - $936,429	-18,470 Reduced 1.47%	1,241,189 $41.6 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $141,681 - $182,730	-3,902 Reduced 0.31%	1,259,659 $57.1 Million
Q3 2019 Oct 18, 2019	BUY	$35.66 - $44.99 $1.89 Million - $2.38 Million	52,956 Added 4.37%	1,263,561 $48.1 Million
Q2 2019 Aug 01, 2019	BUY	$36.57 - $47.97 $397,442 - $521,337	10,868 Added 0.91%	1,210,605 $52.6 Million
Q1 2019 May 03, 2019	BUY	$36.47 - $42.17 $35,558 - $41,115	975 Added 0.08%	1,199,737 $45.7 Million
Q4 2018 Feb 11, 2019	SELL	$41.31 - $52.16 $1.23 Million - $1.55 Million	-29,727 Reduced 2.42%	1,198,762 $51.6 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $992,661 - $1.57 Million	30,218 Added 2.52%	1,228,489 $60.4 Million
Q2 2018 Aug 10, 2018	BUY	$27.5 - $39.8 $4.02 Million - $5.82 Million	146,319 Added 13.91%	1,198,271 $37.2 Million
Q1 2018 May 04, 2018	BUY	$29.98 - $46.35 $1.07 Million - $1.65 Million	35,586 Added 3.5%	1,051,952 $32.8 Million
Q4 2017 Feb 05, 2018	BUY	$31.85 - $46.95 $295,122 - $435,038	9,266 Added 0.92%	1,016,366 $46.4 Million
Q3 2017 Nov 08, 2017	BUY	$35.7 - $39.5 $2.29 Million - $2.53 Million	64,131 Added 6.8%	1,007,100 $37.8 Million
Q2 2017 Aug 10, 2017	BUY	N/A	942,969	942,969 $45 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Investment Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Investment Management Group LLC with notifications on news.

Account